Retraction: Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig 2-positive glioma tumor-initiating cells. | Cancer Res;74(22): 6731-2, 2014 Nov 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Retraction: Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig 2-positive glioma tumor-initiating cells.

Koul, Dimpy; Yao, Jun; Wan, Shuzhen; Yuan, Ying; Sulman, Erik; Lang, Frederick; Yung, W K Alfred; Colman, Howard.

Cancer Res ; 74(22): 6731-2, 2014 Nov 15.

Article in En | MEDLINE | ID: mdl-25398854

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Res Year: 2014 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Res Year: 2014 Document type: Article